C
Colospan
Develops an intraluminal bypass device for colorectal surgery to reduce anastomotic leak complications
About Colospan
Developer of an intraluminal bypass device designed to reduce the rate of diverting stomas and their related complications. The company's devices contain an alternative to divert stoma by providing a temporary intraluminal bypass which helps in reducing the contact of fecal materials with the anastomotic site, reducing the life-threatening symptoms related to clinical anastomotic leaks, enabling doctors to maintain patients' well-being in a safe and effective manner and minimizing post-operative complications for a comfortable recovery.
Source: Dealroom company dataAt a glance
- Founded
- 2009
- Headquarters
- Cambridge, United States
- Sector
- Health Tech & Medtech
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
European Innovation Council
Series A2 investors entered at this stage
TriVentures
EIC Fund
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Colospan on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Colospan on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.